Synthesis and biological evaluation of gemcitabine–lipid conjugate (NEO6002)

Synthesis and biological evaluation of gemcitabine–lipid conjugate (NEO6002) Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor Synthesis and Cytotoxic Activity of Two Novel 1-Dodecylthio-2-decyloxypropyl-3-phosphatidic Acid Conjugates with Gemcitabine and Cytosine Arabinoside Development of potent CPP6–gemcitabine conjugates against human prostate cancer cell line (PC-3) Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-.beta.-D-arabinofuranosylcytosine conjugates of ether lipids Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine Synthesis and in vitro anticancer activity of new gemcitabine-nucleoside analogue dimers containing methyltriazole or ester-methyltriazole linker Synthesis and biological evaluation of nitric oxide-releasing hybrids from gemcitabine and phenylsulfonyl furoxans as anti-tumor agents Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development